Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imonogas vs Espumisan for Functional Dyspepsia
NCT02660372Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Feb 2016
- Primary completion
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of simethicone in functional dyspepsia (FD), sponsored by Johnson & Johnson. Started Feb 2016; status: completed.
02
Drugs
simethicone
03
Conditions
functional dyspepsia (FD)
Beyond the preview
Go deeper on NCT02660372.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02660372.